Market revenue in 2023 | USD 2.2 million |
Market revenue in 2030 | USD 3.0 million |
Growth rate | 4.3% (CAGR from 2023 to 2030) |
Largest segment | New born screening (nbs) |
Fastest growing segment | CRO/Research |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | New Born Screening (NBS), Infectious Disease Testing, Therapeutic Drug Monitoring, CRO/Research, Other Applications, Forensics |
Key market players worldwide | Qiagen NV, PerkinElmer, Roche Holding AG, Shimadzu Corp, Ahlstrom-Munksjö, Danaher Corp, Centogene NV Ordinary Shares, Eastern Business Forms, Archimedlife |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dried blood spot collection cards market will help companies and investors design strategic landscapes.
New born screening (nbs) was the largest segment with a revenue share of 27.27% in 2023. Horizon Databook has segmented the Singapore dried blood spot collection cards market based on new born screening (nbs), infectious disease testing, therapeutic drug monitoring, cro/research, other applications, forensics covering the revenue growth of each sub-segment from 2018 to 2030.
According to WHO, Singapore’s healthcare system ranks sixth and provides the fourth best healthcare infrastructure globally. Singapore’s healthcare system is considered as one of the best systems in Asia. Thus, Singapore dried blood spot collection cards market is expected to grow due to expansion of healthcare delivery system.
Rising investments by the government to facilitate R&D in the field of infectious diseases have been key in facilitating growth. For instance, the government invested USD 19 billion in R&D of infectious diseases during the COVID-19 pandemic to drive efforts to curb infectious diseases.
Although Singapore’s pharmaceutical and biotechnology sector is relatively young, it is growing rapidly. The government has undertaken a series of initiatives to expand biotechnology and biopharmaceutical industries in the country. Singapore’s pharmaceutical manufacturing is growing significantly after the launch of Biomedical Sciences (BMS).
Horizon Databook provides a detailed overview of country-level data and insights on the Singapore dried blood spot collection cards market , including forecasts for subscribers. This country databook contains high-level insights into Singapore dried blood spot collection cards market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account